Characteristics of 91 patients with SVT before cancer diagnosis and 391 cancer patients without a prior SVT
| . | Cancer type, n (%) . | |||||
|---|---|---|---|---|---|---|
| Liver cancer . | Pancreatic cancer . | Myeloproliferative neoplasm . | ||||
| Prior SVT (n = 48) . | No prior SVT (n = 211) . | Prior SVT (n = 20) . | No prior SVT (n = 96) . | Prior SVT (n = 23) . | No prior SVT (n = 84) . | |
| Female | 11 (23) | 36 (17) | 9 (45) | 45 (47) | 17 (74) | 54 (64) |
| Male | 37 (77) | 175 (83) | 11 (55) | 51 (53) | 6 (26) | 30 (36) |
| Median follow-up (IQR), d | 76 (38-182) | 115 (35-496) | 31 (8-63) | 97 (39-259) | 2196 (1161-3133) | 2499 (1699-3026) |
| Age at cancer diagnosis, y | ||||||
| <40 | 2 (4) | 0 | 0 | 0 | 10 (43) | 19 (23) |
| 40-64 | 23 (48) | 96 (45) | 12 (60) | 56 (58) | 11 (48) | 55 (65) |
| 65+ | 23 (48) | 115 (55) | 8 (40) | 40 (42) | 2 (9) | 10 (12) |
| Median age (IQR), y | 65 (58-72) | 66 (60-73) | 61 (57-70) | 63 (57-72) | 42 (34-53) | 47 (41-55) |
| Year of cancer diagnosis | ||||||
| 1994-1999 | 3 (6) | 10 (5) | 0 | 0 | 1 (4) | 1 (1) |
| 2000-2005 | 16 (33) | 67 (32) | 3 (15) | 25 (26) | 10 (44) | 41 (49) |
| 2006-2011 | 29 (61) | 134 (63) | 17 (85) | 71 (74) | 12 (52) | 42 (50) |
| Comorbidity level | ||||||
| Low | 8 (17) | 62 (29) | 6 (30) | 54 (56) | 10 (44) | 56 (67) |
| Moderate | 22 (46) | 76 (36) | 6 (30) | 33 (35) | 4 (17) | 27 (32) |
| Severe | 18 (37) | 73 (35) | 8 (40) | 9 (9) | 9 (39) | 1 (1) |
| Liver disease | 32 (67) | 81 (38) | 4 (20) | 1 (1) | 7 (30) | 2 (2) |
| Pancreatitis | 2 (4) | 7 (3) | 5 (25) | 6 (6) | 1 (4) | 0 |
| Diabetes | 18 (38) | 56 (27) | 8 (40) | 20 (21) | 2 (9) | 2 (2) |
| Chronic obstructive pulmonary disease | 4 (8) | 25 (12) | 4 (20) | 12 (13) | 0 | 4 (5) |
| Heart failure or previous MI | 10 (21) | 24 (11) | 3 (15) | 6 (6) | 1 (4) | 1 (1) |
| Ascites | 14 (29) | 29 (14) | 4 (20) | 4 (4) | 5 (22) | 0 |
| Varices | 14 (29) | 30 (14) | 4 (20) | 0 | 7 (30) | 0 |
| Surgical procedure within previous 90 d | 35 (73) | 100 (47) | 15 (75) | 50 (52) | 15 (65) | 13 (15) |
| . | Cancer type, n (%) . | |||||
|---|---|---|---|---|---|---|
| Liver cancer . | Pancreatic cancer . | Myeloproliferative neoplasm . | ||||
| Prior SVT (n = 48) . | No prior SVT (n = 211) . | Prior SVT (n = 20) . | No prior SVT (n = 96) . | Prior SVT (n = 23) . | No prior SVT (n = 84) . | |
| Female | 11 (23) | 36 (17) | 9 (45) | 45 (47) | 17 (74) | 54 (64) |
| Male | 37 (77) | 175 (83) | 11 (55) | 51 (53) | 6 (26) | 30 (36) |
| Median follow-up (IQR), d | 76 (38-182) | 115 (35-496) | 31 (8-63) | 97 (39-259) | 2196 (1161-3133) | 2499 (1699-3026) |
| Age at cancer diagnosis, y | ||||||
| <40 | 2 (4) | 0 | 0 | 0 | 10 (43) | 19 (23) |
| 40-64 | 23 (48) | 96 (45) | 12 (60) | 56 (58) | 11 (48) | 55 (65) |
| 65+ | 23 (48) | 115 (55) | 8 (40) | 40 (42) | 2 (9) | 10 (12) |
| Median age (IQR), y | 65 (58-72) | 66 (60-73) | 61 (57-70) | 63 (57-72) | 42 (34-53) | 47 (41-55) |
| Year of cancer diagnosis | ||||||
| 1994-1999 | 3 (6) | 10 (5) | 0 | 0 | 1 (4) | 1 (1) |
| 2000-2005 | 16 (33) | 67 (32) | 3 (15) | 25 (26) | 10 (44) | 41 (49) |
| 2006-2011 | 29 (61) | 134 (63) | 17 (85) | 71 (74) | 12 (52) | 42 (50) |
| Comorbidity level | ||||||
| Low | 8 (17) | 62 (29) | 6 (30) | 54 (56) | 10 (44) | 56 (67) |
| Moderate | 22 (46) | 76 (36) | 6 (30) | 33 (35) | 4 (17) | 27 (32) |
| Severe | 18 (37) | 73 (35) | 8 (40) | 9 (9) | 9 (39) | 1 (1) |
| Liver disease | 32 (67) | 81 (38) | 4 (20) | 1 (1) | 7 (30) | 2 (2) |
| Pancreatitis | 2 (4) | 7 (3) | 5 (25) | 6 (6) | 1 (4) | 0 |
| Diabetes | 18 (38) | 56 (27) | 8 (40) | 20 (21) | 2 (9) | 2 (2) |
| Chronic obstructive pulmonary disease | 4 (8) | 25 (12) | 4 (20) | 12 (13) | 0 | 4 (5) |
| Heart failure or previous MI | 10 (21) | 24 (11) | 3 (15) | 6 (6) | 1 (4) | 1 (1) |
| Ascites | 14 (29) | 29 (14) | 4 (20) | 4 (4) | 5 (22) | 0 |
| Varices | 14 (29) | 30 (14) | 4 (20) | 0 | 7 (30) | 0 |
| Surgical procedure within previous 90 d | 35 (73) | 100 (47) | 15 (75) | 50 (52) | 15 (65) | 13 (15) |